3,079 results
Search Results
102. A randomized, double-blind, placebo-controlled study to evaluate the effect of repeated oral doses of pazopanib on cardiac conduction in patients with solid tumors
103. Medication prescribing in frail older people
104. The effect of genetic polymorphisms in UGT2B15 on the pharmacokinetic profile of sipoglitazar, a novel anti-diabetic agent
105. Phase I dose-escalation study of oral vinflunine administered once daily for 6 weeks every 8 weeks in patients with advanced/metastatic solid tumours
106. Pharmacokinetics of docetaxel in gastric cancer patients with malignant ascites
107. Marqibo® (vincristine sulfate liposome injection) improves the pharmacokinetics and pharmacodynamics of vincristine
108. Pharmacokinetic and pharmacodynamic effects of comedication of clopidogrel and dabigatran etexilate in healthy male volunteers
109. Gender-specific elimination of continuous-infusional 5-fluorouracil in patients with gastrointestinal malignancies: results from a prospective population pharmacokinetic study
110. Pharmacokinetics of transdermal buprenorphine patch in the elderly
111. Successful ganciclovir therapy in a patient with human herpesvirus-6 encephalitis after unrelated cord blood transplantation: usefulness of longitudinal measurements of viral load in cerebrospinal fluid
112. Simultaneous determination of NNK and its seven metabolites in rabbit blood by hydrophilic interaction liquid chromatography–tandem mass spectrometry
113. Optimizing hollow-fiber-based pharmacokinetic assay via chemical stability study to account for inaccurate simulated drug clearance of rifampicin
114. Leflunomide in dialysis patients with rheumatoid arthritis—a pharmacokinetic study
115. In vitro cytotoxicity, pharmacokinetics, tissue distribution, and metabolism of small-molecule protein kinase D inhibitors, kb-NB142-70 and kb-NB165-09, in mice bearing human cancer xenografts
116. Absorption, metabolism and excretion of [14C]pomalidomide in humans following oral administration
117. Comparison of pharmacokinetics and safety profiles of two capecitabine tablet formulations in patients with colon, colorectal or breast cancer
118. Effects of famotidine or an antacid preparation on the pharmacokinetics of nilotinib in healthy volunteers
119. Evaluation of the pharmacokinetics and safety of bosutinib in patients with chronic hepatic impairment and matched healthy subjects
120. Phase 1 study of trebananib (AMG 386), an angiogenesis targeting angiopoietin-1/2 antagonist, in Japanese patients with advanced solid tumors
121. Separation of advanced from mild hepatic fibrosis by quantification of the hepatobiliary uptake of Gd-EOB-DTPA
122. A Phase I study of pazopanib in combination with gemcitabine in patients with advanced solid tumors
123. Time-Dependent Changes of Oxime K027 Concentrations in Different Parts of Rat Central Nervous System
124. Irinotecan Loaded in Eluting Beads: Preclinical Assessment in a Rabbit VX2 Liver Tumor Model
125. Efficacy, pharmacokinetics, and safety of adalimumab in pediatric patients with juvenile idiopathic arthritis in Japan
126. Pharmacokinetics of eribulin mesylate in patients with solid tumors and hepatic impairment
127. Brain-targeting research of 10-O-nicotinate ginkgolide B: a new prodrug of ginkgolide B
128. Comparison of the pharmacokinetics of sulfamethoxazole in native Han and Tibetan male Chinese volunteers living at high altitude
129. Cisplatin Pharmacokinetics in Nontumoral Pig Liver Treated With Intravenous or Transarterial Hepatic Chemoembolization
130. Phase I study of nelfinavir in liposarcoma
131. Retinoic acid as target for local pharmacokinetic interaction with modafinil in neural cells
132. Pharmacokinetics and Tissue Distribution Study of Tryptanthrin in Rats by RP-HPLC with DAD Detector
133. Comparison of the pharmacokinetics of a new 30 mg modified-release tablet formulation of metoclopramide for once-a-day administration versus 10 mg immediate-release tablets: a single and multiple-dose, randomized, open-label, parallel study in healthy male subjects
134. Toxicokinetics of metformin-associated lactic acidosis with continuous renal replacement therapy
135. Absorption, disposition, metabolic fate and elimination of the anti-epileptic drug lacosamide in humans: mass balance following intravenous and oral administration
136. Pharmacokinetics and pharmacodynamics of single-dose oral tolvaptan in fasted and non-fasted states in healthy Caucasian and Japanese male subjects
137. Fluoxetine pharmacogenetics in child and adult populations
138. Single-dose pharmacokinetics of lenalidomide in healthy volunteers: dose proportionality, food effect, and racial sensitivity
139. Relative bioavailability and pharmacodynamic effects of methantheline compared with atropine in healthy subjects
140. Pharmacokinetics of the novel PAR-1 antagonist vorapaxar in patients with hepatic impairment
141. Pharmacokinetics of inhaled colistimethate sodium (CMS) in mechanically ventilated critically ill patients
142. A phase I and pharmacokinetic study of elisidepsin (PM02734) in patients with advanced solid tumors
143. A phase 1 study of vinflunine in combination with trastuzumab for the treatment for HER2-positive metastatic breast cancer
144. A Sensitive and Selective LC-MS Method for the Determination of Lurasidone in Rat Plasma, Bile, and Urine
145. A novel method for quantification of sulfolane (a metabolite of busulfan) in plasma by gas chromatography–tandem mass spectrometry
146. Influence of UDP-glucuronosyltransferase polymorphisms on valproic acid pharmacokinetics in Chinese epilepsy patients
147. Pharmacokinetics, pharmacodynamics, and safety of clevidipine after prolonged continuous infusion in subjects with mild to moderate essential hypertension
148. An open-label study to evaluate a single-dose of cinacalcet in pediatric dialysis subjects
149. Absorption of different oral dosage forms of oxycodone in the elderly: a cross-over clinical trial in patients undergoing cystoscopy
150. Pharmacokinetic modelling of N-(4-[18F]fluorobenzoyl)interleukin-2 binding to activated lymphocytes in an xenograft model of inflammation
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.